News for Entasis Therapeutics Holdings Inc. (ETTX)

HIGH POINT, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the...

Innoviva, Inc. , a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer,... | September 8, 2022

Read Sol-Gel Technologies (NASDAQ:SLGL) vs. Entasis Therapeutics (NASDAQ:ETTX) Critical Comparison at ETF Daily News

Read Entasis Therapeutics (NASDAQ:ETTX) and Newron Pharmaceuticals (OTCMKTS:NWPHF) Head-To-Head Analysis at ETF Daily News

Suncor Energy Inc.

Read Innoviva, Inc. Purchases 7,598,814 Shares of Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Stock at ETF Daily News

Read Innoviva, Inc. Acquires 11,671,662 Shares of Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Stock at ETF Daily News

US producer prices likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades.

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential...